Indian
Delivery race among Indian grocery startups brings road safety risks
"Ten minutes is very sharp," said a former road secretary, Vijay...
Omicron in community transmission stage in India, dominant in metros reporting surge: INSACOG
“Omicron is now in community transmission in India and has become...
India reports over 3.33 lakh new COVID-19 cases, daily positivity rate at 17.78 pc
As many as 525 fatalities were registered in the last 24 hours,...
Aspirational districts now eliminating barriers to progress: PM Modi
Launched by the prime minister in January 2018, the aspirational...
International
“Coronavirus effects will be felt for decades”:WHO
Facebook raises settlement to $650 million in facial recognition lawsuit
The social media giant reached a $550 million settlement in January regarding the same lawsuit, which started in 2015, when Illinois users accused the company of violating the state’s Biometric Information Privacy Act in collecting biometric data.
In 2019, a U.S. Circuit Court of Appeals court swatted away Facebook’s claim that facial recognition data did not count as biometric data, stating that “development of face template using facial-recognition technology without consent (as alleged here) invades an individual’s private affairs and concrete interests.”
Southeast Asia poverty to surge in ‘socio-economic crisis’:U.N.
“Without alternative income, formal social protection systems or savings to buffer these shocks, workers and their families will be pushed into poverty, reversing decades of poverty reduction.”
The region-wide economy was expected to contract by 0.4 per cent in 2020, it said, while remittances from Southeast Asians working abroad were likely to fall by 13 per cent or $10 billion.
Gilead raises sales outlook to include COVID-19 treatment remdesivir
Demand for remdesivir continues to outstrip supply in many parts of the world.
Gilead’s chief executive, Daniel O’Day, on a conference call, said the company expects by the end of September to be producing enough remdesivir to meet real-time global demand.
Gilead said it still expects to manufacturer 2 million or more remdesivir treatment courses cumulatively in 2020, and its revenue outlook reflects expected sales of up to 1.5 million courses this year.
Briefs
No Results Found
The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.
Events
No Results Found
The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.

Articles
No Results Found
The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.
Features
No Results Found
The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.
Data
No Results Found
The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.
Interviews
No Results Found
The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.
Facts
No Results Found
The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.
